2009Academic Journal of Second Military Medical UniversityRequires access

Effects of GHSC-73 on proliferation and cell cycle of human hepatocellular carcinoma HepG2 cells

Binghua Jiao

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of β-D-glucosyl-(1-4)-α-L-thevetosides of 17β-digitoxigenin (GHSC-73),an isolate from the seeds of Cerbera manghas L.,on cell growth and cell cycle regulation of human hepatocellular carcinoma cell line HepG2,and to discuss the related mechanism.Methods:HepG2 cells were treated with different concentrations (0-80 μmol/L) of GHSC-73.Cell viability was determined using MTT assay at 24,48,and 72 h after treatment.Cell cycle distribution was assessed by flow cytometry after propidium iodide (PI) staining.Expression of the S phase associated genes GADD153,cyclin D1,cyclin A2,DHFR,TYMS,and p21 was determined by real-time RT-PCR before and after GHSC-73 treatment.Results:GHSC-73 inhibited the cell proliferation of HepG2 cells in a dose-and time-dependent manner.The values of IC50 were (5.18±0.21),(0.37±0.08),and (1.66±0.16) μmol/L at 24,48,and 72 h,respectively.Compared with control group,the proportion of cells in S phase increased in the treatment group with the prolongation of treatment,the cells in G0/G1 phase gradually decreased (P0.05),and cells in G2/M phase remained unchanged,indicating that GHSC-73 blocked HepG2 cell in S phase.Real-time RT-PCR showed that cyclin A2,DHFR,and TYMS were down-regulated,and p21,GADD153,and cyclin D1 were up-regulated,which might be associated with the GHSC-73-induced S phase arrest in HepG2 cells.Conclusion:GHSC-73 can inhibit growth of HepG2 cells by inducing S phase arrest; down-regulation of cyclin A2,DHFR,and TYMS genes and up-regulation of p21,GADD153,and cyclin D1 genes might participate in the induction of arrest.

About this research paper

What this paper is about

Objective:To investigate the effects of β-D-glucosyl-(1-4)-α-L-thevetosides of 17β-digitoxigenin (GHSC-73),an isolate from the seeds of Cerbera manghas L.,on cell growth and cell cycle regulation of human hepatocellular carcinoma cell line HepG2,and to discuss the related mechanism.Methods:HepG2 cells were treated with different concentrations (0-80 μmol/L) of GHSC-73.Cell viability was determined using MTT assay at 24,48,and 72 h after treatment.Cell cycle distribution was assessed by flow cytometry after propidium iodide (PI) staining.Expression of the S phase associated genes GADD153,cyclin D1,cyclin A2,DHFR,TYMS,and p21 was determined by real-time RT-PCR before and after GHSC-73 treatment.Results:GHSC-73 inhibited the cell proliferation of HepG2 cells in a dose-and time-dependent manner.The values of IC50 were (5.18±0.21),(0.37±0.08),and (1.66±0.16) μmol/L at 24,48,and 72 h,respectively.Compared with control group,the proportion of cells in S phase increased in the treatment group with the prolongation of treatment,the cells in G0/G1 phase gradually decreased (P0.05),and cells in G2/M phase remained unchanged,indicating that GHSC-73 blocked HepG2 cell in S phase.Real-time RT-PCR showed that cyclin A2,DHFR,and TYMS were down-regulated,and p21,GADD153,and cyclin D1 were up-regulated,which might be associated with the GHSC-73-induced S phase arrest in HepG2 cells.Conclusion:GHSC-73 can inhibit growth of HepG2 cells by inducing S phase arrest; down-regulation of cyclin A2,DHFR,and TYMS genes and up-regulation of p21,GADD153,and cyclin D1 genes might participate in the induction of arrest.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of β-D-glucosyl-(1-4)-α-L-thevetosides of 17β-digitoxigenin (GHSC-73),an isolate from the seeds of Cerbera manghas L.,on cell growth and cell cycle regulation of human hepatocellular carcinoma cell line HepG2,and to discuss the related mechanism.Methods:HepG2 cells were treated with different concentrations (0-80 μmol/L) of GHSC-73.Cell viability was determined using MTT assay at 24,48,and 72 h after treatment.Cell cycle distribution was assessed by flow cytometry after propidium iodide (PI) staining.Expression of the S phase associated genes GADD153,cyclin D1,cyclin A2,DHFR,TYMS,and p21 was determined by real-time RT-PCR before and after GHSC-73 treatment.Results:GHSC-73 inhibited the cell proliferation of HepG2 cells in a dose-and time-dependent manner.The values of IC50 were (5.18±0.21),(0.37±0.08),and (1.66±0.16) μmol/L at 24,48,and 72 h,respectively.Compared with control group,the proportion of cells in S phase increased in the treatment group with the prolongation of treatment,the cells in G0/G1 phase gradually decreased (P0.05),and cells in G2/M phase remained unchanged,indicating that GHSC-73 blocked HepG2 cell in S phase.Real-time RT-PCR showed that cyclin A2,DHFR,and TYMS were down-regulated,and p21,GADD153,and cyclin D1 were up-regulated,which might be associated with the GHSC-73-induced S phase arrest in HepG2 cells.Conclusion:GHSC-73 can inhibit growth of HepG2 cells by inducing S phase arrest; down-regulation of cyclin A2,DHFR,and TYMS genes and up-regulation of p21,GADD153,and cyclin D1 genes might participate in the induction of arrest.

Key concepts: Propidium iodide, Cell cycle, Cell growth, Cyclin D1, Flow cytometry, Cyclin B1, Molecular biology, Apoptosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of GHSC-73 on proliferation and cell cycle of human hepatocellular carcinoma HepG2 cells — Research Paper | ScholarLens